Equity Analysis

Company News

    Infinium Pharmachem Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    78690
    INE0MRE01011
    63.4381773
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    INFINIUM
    33.15
    367.76
    EPS(TTM)
    Face Value()
    Div & Yield %:
    7.12
    10
    0
     
Vesuvius India shares surge on stock split plan
Feb 20,2025
The board will also review and approve audited financial results for the year ended 31 December 2024 (FY24), and consider a dividend.

The stock split proposal is subject to shareholder and regulatory approvals.

Vesuvius India is primarily engaged in the manufacturing and trading of refractory goods. The company also provides services in relation to refractory goods.

Net profit of Vesuvius India rose 13.57% to Rs 68.46 crore while net sales rose 8.15% to Rs 443.52 crore in Q3 September 2024 over Q4 September 2023.